Apr 21, 2026 08:37AM

Apr 21, 2026 06:52AM

Mar 27, 2026 06:14AM

Mar 22, 2026 09:19PM

Mar 10, 2026 10:07PM

Mar 1, 2026 06:49PM

Feb 9, 2026 10:34PM Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China

Jan 25, 2026 11:52PM

Jan 25, 2026 08:37PM

Nov 26, 2025 06:03AM

Nov 26, 2025 04:42AM

Jul 16, 2025 12:50AM

Mar 4, 2025 02:22AM

Jan 27, 2025 06:46PM FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease

Jan 14, 2025 07:03PM

Oct 31, 2024 11:56PM

Aug 5, 2024 11:15PM

Jun 10, 2024 04:50AM

Jun 11, 2023 08:13PM

Jun 7, 2023 11:32PM

15,434 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All